Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review-Reference-Cited by-同舟云学术

Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review

Published:2022-05-09 Issue:12 Volume:46 Page:2371-2381
ISSN:0160-564X
Container-title:Artificial Organs
language:en
Short-container-title:Artificial Organs

Author:

Sanfilippo Filippo¹^ORCID,Currò Jessica Marika²,La Via Luigi¹,Dezio Veronica¹,Martucci Gennaro³^ORCID,Brancati Serena⁴,Murabito Paolo¹⁴,Pappalardo Federico⁴⁵,Astuto Marinella¹⁴

Affiliation:

1. Department of Anaesthesia and Intensive Care A.O.U. “Policlinico‐San Marco” Catania Italy

2. School of Anaesthesia and Intensive Care University “Magna Graecia” Catanzaro Italy

3. Department of Anesthesia and Intensive Care IRCCS‐ISMETT, UPMC Italy Palermo Italy

4. Department of General Surgery and Medical‐Surgical Specialties University of Catania Catania Italy

5. CardioThoracic and Vascular Anesthesia and Intensive Care AO SS Antonio e Biagio e Cesare Arrigo Alessandria Italy

Publisher

Wiley

Subject

Biomedical Engineering,General Medicine,Biomaterials,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aor.14276

Reference48 articles.

1. Anticoagulation Management and Antithrombin Supplementation Practice during Veno-venous Extracorporeal Membrane Oxygenation

2. Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality

3. New synthetic inhibitors of C1r̄, C1 esterase, thrombin, plasmin, kallikrein and trypsin

4. Inhibitory mechanism of human platelet aggregation by nafamostat mesilate

5. Inhibitory effect of a new synthetic protease inhibitor (FUT‐175) on the coagulation system;Hitomi Y;Haemostasis,1985

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate;Journal of Intensive Medicine;2024-10

2. Anticoagulation Strategies During ECMO Application;Evolving Therapies and Technologies in Extracorporeal Membrane Oxygenation [Working Title];2024-06-05

3. New strategy to treat spinal cord injury: Nafamostat mesilate suppressed NLRP3-mediated pyroptosis during acute phase;International Immunopharmacology;2024-06

4. Brain injury plasma biomarkers in patients on veno-arterial extracorporeal membrane oxygenation: A pilot prospective observational study;Perfusion;2024-05-17

5. Management of cardiopulmonary bypass in patients with ischemic and hemorrhagic strokes in surgery for active infective endocarditis;Indian Journal of Thoracic and Cardiovascular Surgery;2023-12-19